Drug Trial Radar · NCT07203287
Risk of Acute Complications With Rocuronium vs Cisatracurium in Patients With Chronic Kidney Disease
Last checked: Nov 20, 2026Latest source record: Oct 20, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
490
Planned (sponsor's estimate)
Start
Aug 26, 2025
Primary completion
Dec 31, 2026
Study completion Aug 26, 2027
Sponsor
- Lead sponsor
- The University of Texas Medical Branch, GalvestonAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- Oct 2, 2025
Design
- Study type
- Interventional
- Phase
- Phase 4
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Single (outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 80 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
The purpose of the study is to determine which combination of neuromuscular blocking agent and reversal agent is safer to use during anesthesia for patients with chronic kidney disease. The main question it aims to answer is "The use of Cisatracurium with neostigmine leads to less post-operative pulmonary complications than Rocuronium with sugammadex."
Conditions
- Post Operative Pulmonary Complications
- Neuromuscular Blockade
- General Anesthesia
Interventions
RocuroniumDrug
Will be assessing neuromuscular blockade with rocuronium and reversal with sugammadex
CisatracuriumDrug
Will be assessing neuromuscular blockade with neostigmine and reversal with neostigmine
SugammadexDrug
Will be assessing neuromuscular blockade with rocuronium and reversal with sugammadex
NeostigmineDrug
Will be assessing neuromuscular blockade with neostigmine and reversal with neostigmine
Primary outcomes
What the sponsor says the trial is designed to measure.
- Post Operative Pulmonary Complications (PPCs)Time frame: 7 days
Locations
1 site in 1 country. Site status is shown where the registry gives one.
University of Texas Medical Branch
Galveston, Texas · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.